RECK: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
Matt Pijoan (talk | contribs) m (1 revision imported) |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
'''Reversion-inducing-cysteine-rich protein with kazal motifs''', also known as '''RECK''', is a human [[gene]],<ref name="entrez">{{cite web | title = Entrez Gene: RECK reversion-inducing-cysteine-rich protein with kazal motifs| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8434| accessdate = }}</ref> thought to be a [[metastasis suppressor]]. | |||
}} | |||
'''Reversion-inducing-cysteine-rich protein with kazal motifs''', also known as '''RECK''', is a human [[gene]],<ref name="entrez">{{cite web | title = Entrez Gene: RECK reversion-inducing-cysteine-rich protein with kazal motifs| url = | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis.<ref name="entrez"> | | summary_text = The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis.<ref name="entrez"/> It is one of the targets of an oncomiR, [[MIRN21]]. | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | *{{cite journal |vauthors=Takahashi C, Sheng Z, Horan TP, etal |title=Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=95 |issue= 22 |pages= 13221–6 |year= 1998 |pmid= 9789069 |doi=10.1073/pnas.95.22.13221 | pmc=23764 }} | ||
*{{cite journal | author=Gerstein M |title=Measurement of the effectiveness of transitive sequence comparison, through a third 'intermediate' sequence. |journal=Bioinformatics |volume=14 |issue= 8 |pages= | *{{cite journal | author=Gerstein M |title=Measurement of the effectiveness of transitive sequence comparison, through a third 'intermediate' sequence. |journal=Bioinformatics |volume=14 |issue= 8 |pages= 707–14 |year= 1998 |pmid= 9789096 |doi=10.1093/bioinformatics/14.8.707 }} | ||
*{{cite journal | *{{cite journal |vauthors=Oh J, Takahashi R, Kondo S, etal |title=The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. |journal=Cell |volume=107 |issue= 6 |pages= 789–800 |year= 2002 |pmid= 11747814 |doi=10.1016/S0092-8674(01)00597-9 }} | ||
*{{cite journal | *{{cite journal |vauthors=Eisenberg I, Hochner H, Sadeh M, etal |title=Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene. |journal=Cytogenet. Genome Res. |volume=97 |issue= 1–2 |pages= 58–61 |year= 2003 |pmid= 12438739 |doi=10.1159/000064042 }} | ||
*{{cite journal | *{{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }} | ||
*{{cite journal | *{{cite journal |vauthors=Masui T, Doi R, Koshiba T, etal |title=RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. |journal=Clin. Cancer Res. |volume=9 |issue= 5 |pages= 1779–84 |year= 2004 |pmid= 12738734 |doi= }} | ||
*{{cite journal | | *{{cite journal | vauthors=Liu LT, Chang HC, Chiang LC, Hung WC |title=Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. |journal=Cancer Res. |volume=63 |issue= 12 |pages= 3069–72 |year= 2003 |pmid= 12810630 |doi= }} | ||
*{{cite journal | *{{cite journal |vauthors=Ota T, Suzuki Y, Nishikawa T, etal |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }} | ||
*{{cite journal | *{{cite journal |vauthors=Humphray SJ, Oliver K, Hunt AR, etal |title=DNA sequence and analysis of human chromosome 9. |journal=Nature |volume=429 |issue= 6990 |pages= 369–74 |year= 2004 |pmid= 15164053 |doi= 10.1038/nature02465 | pmc=2734081 }} | ||
*{{cite journal | *{{cite journal |vauthors=Takeuchi T, Hisanaga M, Nagao M, etal |title=The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. |journal=Clin. Cancer Res. |volume=10 |issue= 16 |pages= 5572–9 |year= 2005 |pmid= 15328199 |doi= 10.1158/1078-0432.CCR-03-0656 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Simizu S, Takagi S, Tamura Y, Osada H |title=RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. |journal=Cancer Res. |volume=65 |issue= 16 |pages= 7455–61 |year= 2005 |pmid= 16103099 |doi= 10.1158/0008-5472.CAN-04-4446 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Hsu MC, Chang HC, Hung WC |title=HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. |journal=J. Biol. Chem. |volume=281 |issue= 8 |pages= 4718–25 |year= 2006 |pmid= 16377629 |doi=10.1074/jbc.M510937200 }} | ||
*{{cite journal | *{{cite journal |vauthors=Correa TC, Brohem CA, Winnischofer SM, etal |title=Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness. |journal=J. Cell. Biochem. |volume=99 |issue= 1 |pages= 156–67 |year= 2006 |pmid= 16791855 |doi= 10.1002/jcb.20917 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Chang HC, Cho CY, Hung WC |title=Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. |journal=Cancer Res. |volume=66 |issue= 17 |pages= 8413–20 |year= 2007 |pmid= 16951151 |doi= 10.1158/0008-5472.CAN-06-0685 }} | ||
*{{cite journal | *{{cite journal |vauthors=Lei H, Hemminki K, Altieri A, etal |title=Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. |journal=Breast Cancer Res. Treat. |volume=103 |issue= 1 |pages= 61–9 |year= 2007 |pmid= 17033924 |doi= 10.1007/s10549-006-9345-2 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Chang HC, Cho CY, Hung WC |title=Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. |journal=Cancer Sci. |volume=98 |issue= 2 |pages= 169–73 |year= 2007 |pmid= 17233834 |doi= 10.1111/j.1349-7006.2006.00367.x }} | ||
*{{cite journal | *{{cite journal |vauthors=Kang HG, Kim HS, Kim KJ, etal |title=RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. |journal=J. Orthop. Res. |volume=25 |issue= 5 |pages= 696–702 |year= 2007 |pmid= 17262820 |doi= 10.1002/jor.20323 }} | ||
*{{cite journal | *{{cite journal |vauthors=Mori T, Moriuchi R, Okazaki E, etal |title=Tgat oncoprotein functions as an inhibitor of RECK by association of the unique C-terminal region. |journal=Biochem. Biophys. Res. Commun. |volume=355 |issue= 4 |pages= 937–43 |year= 2007 |pmid= 17328864 |doi= 10.1016/j.bbrc.2007.02.051 }} | ||
*{{cite journal | *{{cite journal |vauthors=Miki T, Takegami Y, Okawa K, etal |title=The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. |journal=J. Biol. Chem. |volume=282 |issue= 16 |pages= 12341–52 |year= 2007 |pmid= 17329256 |doi=10.1074/jbc.M610948200 }} | ||
*{{cite journal | *{{cite journal |vauthors=Cho CY, Wang JH, Chang HC, etal |title=Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. |journal=J. Cell. Physiol. |volume=213 |issue= 1 |pages= 65–9 |year= 2007 |pmid= 17443689 |doi= 10.1002/jcp.21089 }} | ||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{ | <!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | ||
{{ | {{PBB_Controls | ||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{gene-9-stub}} |
Latest revision as of 07:37, 10 January 2019
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Reversion-inducing-cysteine-rich protein with kazal motifs, also known as RECK, is a human gene,[1] thought to be a metastasis suppressor.
The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis.[1] It is one of the targets of an oncomiR, MIRN21.
References
Further reading
- Takahashi C, Sheng Z, Horan TP, et al. (1998). "Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK". Proc. Natl. Acad. Sci. U.S.A. 95 (22): 13221–6. doi:10.1073/pnas.95.22.13221. PMC 23764. PMID 9789069.
- Gerstein M (1998). "Measurement of the effectiveness of transitive sequence comparison, through a third 'intermediate' sequence". Bioinformatics. 14 (8): 707–14. doi:10.1093/bioinformatics/14.8.707. PMID 9789096.
- Oh J, Takahashi R, Kondo S, et al. (2002). "The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis". Cell. 107 (6): 789–800. doi:10.1016/S0092-8674(01)00597-9. PMID 11747814.
- Eisenberg I, Hochner H, Sadeh M, et al. (2003). "Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene". Cytogenet. Genome Res. 97 (1–2): 58–61. doi:10.1159/000064042. PMID 12438739.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Masui T, Doi R, Koshiba T, et al. (2004). "RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis". Clin. Cancer Res. 9 (5): 1779–84. PMID 12738734.
- Liu LT, Chang HC, Chiang LC, Hung WC (2003). "Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion". Cancer Res. 63 (12): 3069–72. PMID 12810630.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). "DNA sequence and analysis of human chromosome 9". Nature. 429 (6990): 369–74. doi:10.1038/nature02465. PMC 2734081. PMID 15164053.
- Takeuchi T, Hisanaga M, Nagao M, et al. (2005). "The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer". Clin. Cancer Res. 10 (16): 5572–9. doi:10.1158/1078-0432.CCR-03-0656. PMID 15328199.
- Simizu S, Takagi S, Tamura Y, Osada H (2005). "RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines". Cancer Res. 65 (16): 7455–61. doi:10.1158/0008-5472.CAN-04-4446. PMID 16103099.
- Hsu MC, Chang HC, Hung WC (2006). "HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion". J. Biol. Chem. 281 (8): 4718–25. doi:10.1074/jbc.M510937200. PMID 16377629.
- Correa TC, Brohem CA, Winnischofer SM, et al. (2006). "Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness". J. Cell. Biochem. 99 (1): 156–67. doi:10.1002/jcb.20917. PMID 16791855.
- Chang HC, Cho CY, Hung WC (2007). "Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation". Cancer Res. 66 (17): 8413–20. doi:10.1158/0008-5472.CAN-06-0685. PMID 16951151.
- Lei H, Hemminki K, Altieri A, et al. (2007). "Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression". Breast Cancer Res. Treat. 103 (1): 61–9. doi:10.1007/s10549-006-9345-2. PMID 17033924.
- Chang HC, Cho CY, Hung WC (2007). "Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer". Cancer Sci. 98 (2): 169–73. doi:10.1111/j.1349-7006.2006.00367.x. PMID 17233834.
- Kang HG, Kim HS, Kim KJ, et al. (2007). "RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness". J. Orthop. Res. 25 (5): 696–702. doi:10.1002/jor.20323. PMID 17262820.
- Mori T, Moriuchi R, Okazaki E, et al. (2007). "Tgat oncoprotein functions as an inhibitor of RECK by association of the unique C-terminal region". Biochem. Biophys. Res. Commun. 355 (4): 937–43. doi:10.1016/j.bbrc.2007.02.051. PMID 17328864.
- Miki T, Takegami Y, Okawa K, et al. (2007). "The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways". J. Biol. Chem. 282 (16): 12341–52. doi:10.1074/jbc.M610948200. PMID 17329256.
- Cho CY, Wang JH, Chang HC, et al. (2007). "Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells". J. Cell. Physiol. 213 (1): 65–9. doi:10.1002/jcp.21089. PMID 17443689.
This article on a gene on human chromosome 9 is a stub. You can help Wikipedia by expanding it. |